Chitosan-based formulations of drugs, imaging agents and biotherapeutics

Advanced Drug Delivery Reviews

Volumn 62, Issue 1, 2010, Pages 1-2

  Amidi, Maryam ^a   Hennink, Wim E ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; CHITOSAN; CHITOSAN DERIVATIVE; CONTRAST MEDIUM; DRUG CARRIER; NANOPARTICLE; PLASMID DNA;

BIODEGRADABILITY; CANCER THERAPY; CELL MEMBRANE PERMEABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRUG TARGETING; EDITORIAL; EXCIPIENT COMPATIBILITY; MOLECULAR IMAGING; MOLECULAR WEIGHT; MUCOADHESION; PRIORITY JOURNAL; PUBLICATION;

ANIMALS; BIOLOGICAL PRODUCTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CONTRAST MEDIA; HUMANS;

EID: 75149124279     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.12.006     Document Type: Editorial

References (15)

1. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87 (2003) 187-198
2. Schipper N.G., Olsson S., Hoogstraate J.A., deBoer A.G., Varum K.M., and Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 14 (1997) 923-929
3. van der Lubben I.M., Verhoef J.C., Borchard G., and Junginger H.E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 14 (2001) 201-207
4. Illum L., Farraj N.F., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 (1994) 1186-1189
5. Alpar H.O., Somavarapu S., Atuah K.N., and Bramwell V.W. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev. 57 (2005) 411-430
6. Amidi M., Romeijn S.G., Borchard G., Junginger H.E., Hennink W.E., and Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release 111 (2006) 107-116
7. Lai W.F., and Lin M.C. Nucleic acid delivery with chitosan and its derivatives. J. Control. Release 134 (2009) 158-168
8. Hassan E.E., Parish R.C., and Gallo J.M. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm. Res. 9 (1992) 390-397
9. A. Kumar, P.K. Jena, S. Behera, R.F. Lockey, S. Mohapatra. Nanomedicine: Nanotechnology, Biology and Medicine (2009) In Press, Corrected Proof.
10. Kim J.-H., Kim Y.-S., Kim S., Park J.H., Kim K., Choi K., Chung H., Jeong S.Y., Park R.-W., Kim I.-S., and Kwon I.C. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J. Control. Release 111 (2006) 228-234
11. Bowman K., and Leong K.W. Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomedicine 1 (2006) 117-128
12. Shi C., Zhu Y., Ran X., Wang M., Su Y., and Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J. Surg. Res. 133 (2006) 185-192
13. Kim I.Y., Seo S.J., Moon H.S., Yoo M.-K., Park I.Y., Kim B.C., and Cho C.S. Biotechnol. Adv. 26 (2008) 1-21
14. Chopra S., Mahdi S., Kaur J., Iqbal Z., Talegaonkar S., and Ahmad F.J. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery. J. Pharm. Pharmacol. 58 (2006) 1021-1032
15. Werle M., Takeuchi H., and Bernkop-Schnurch A. Modified chitosans for oral drug delivery. J. Pharm. Sci. 98 (2009) 1643-1656